232 related articles for article (PubMed ID: 29877249)
21. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.
Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D
Mod Pathol; 2024 May; 37(7):100519. PubMed ID: 38777036
[TBL] [Abstract][Full Text] [Related]
22. A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell Leukemia/Lymphoma.
Tamaki T; Karube K; Sakihama S; Tsuruta Y; Awazawa R; Hayashi M; Nakada N; Matsumoto H; Yagi N; Ohshiro K; Nakazato I; Kitamura S; Nishi Y; Miyagi T; Yamaguchi S; Nakachi S; Morishima S; Masuzaki H; Takahashi K; Fukushima T; Wada N
Mod Pathol; 2023 Aug; 36(8):100169. PubMed ID: 36997002
[TBL] [Abstract][Full Text] [Related]
23. Differential diagnosis of angioimmunoblastic T-cell lymphoma with seropositivity for anti-HTLV antibody from adult T-cell leukemia/lymphoma.
Chuang SS; Ichinohasama R; Chu JS; Ohshima K
Int J Hematol; 2010 May; 91(4):687-91. PubMed ID: 20198459
[TBL] [Abstract][Full Text] [Related]
24. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Nakashima K; Kawamoto K; Yamada K; Yanagida E; Muta H; Moritsubo M; Umeno T; Suzuki T; Seto M; Ohshima K
Ann Hematol; 2020 May; 99(5):1093-1098. PubMed ID: 32157421
[TBL] [Abstract][Full Text] [Related]
26. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.
Shi Y; Wang H; Liu Y; Long M; Ding N; Mi L; Lai Y; Zhou L; Diao X; Li X; Liu W; Zhu J
Chin J Cancer Res; 2023 Oct; 35(5):536-549. PubMed ID: 37969960
[TBL] [Abstract][Full Text] [Related]
27. The curious origins of angioimmunoblastic T-cell lymphoma.
Cortés JR; Palomero T
Curr Opin Hematol; 2016 Jul; 23(4):434-43. PubMed ID: 27177312
[TBL] [Abstract][Full Text] [Related]
28. Detection of Tax-specific CTLs in lymph nodes of adult T-cell leukemia/lymphoma patients and its association with Foxp3 positivity of regulatory T-cell function.
Ichikawa A; Miyoshi H; Arakawa F; Kiyasu J; Sato K; Niino D; Kimura Y; Yoshida M; Kawano R; Muta H; Sugita Y; Ohshima K
Oncol Lett; 2017 Jun; 13(6):4611-4618. PubMed ID: 28599462
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphoma.
Yanagida E; Miyoshi H; Takeuchi M; Yoshida N; Nakashima K; Yamada K; Umeno T; Shimasaki Y; Furuta T; Seto M; Ohshima K
Hematol Oncol; 2020 Dec; 38(5):680-688. PubMed ID: 32569413
[TBL] [Abstract][Full Text] [Related]
30. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
[TBL] [Abstract][Full Text] [Related]
31. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
[TBL] [Abstract][Full Text] [Related]
32. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
Fujisawa M; Chiba S; Sakata-Yanagimoto M
J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
[TBL] [Abstract][Full Text] [Related]
33. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
[TBL] [Abstract][Full Text] [Related]
34. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract][Full Text] [Related]
36. Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.
Chen Z; Zhu Q; Deng X; Yao W; Zhang W; Liu W; Tang Y; Zhao S
Front Immunol; 2022; 13():987227. PubMed ID: 36325319
[TBL] [Abstract][Full Text] [Related]
37. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
38. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
40. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]